breast-cancer / English

add

(MedPage Today) -- BERLIN -- Administering bone-modifying agents (BMAs) every 24 weeks after long-term use was a safe and effective strategy for patients with bone metastases from breast cancer, and also appeared to be safe in prostate…

Claire Hughes, 46, says she has spoken about her diagnosis to encourage any woman who finds a lump to get it checked

Prior to the Chicago Bears matchup with the New Orleans Saints, cancer survivor Amy Cash and her family got to meet the team at Halas Hall. They watched practice, afterwards which Williams gave Cash a jersey. In turn, Cash had a gift for…

In a landmark moment at the ESMO Congress 2025, pivotal studies have unveiled compelling evidence that a new class of anti-cancer agents—antibody-drug conjugates (ADCs)—can dramatically improve outcomes for patients with early-stage HER2…

Patients who had more cells had better outcomes, particularly for aggressive types such as triple-negative breast cancer

Researchers believe a groundbreaking new drug can offer hope to those diagnosed with this deadly breast cancer, creating a new standard of care and improved survival rates.

Claire Hughes, Labour MP for Bangor Aberconwy, said she will undergo surgery on Friday.

Claire Hughes, Labour MP for Bangor Aberconwy, said she will undergo surgery on Friday.

Claire Hughes, Labour MP for Bangor Aberconwy, said she will undergo surgery on Friday.

Claire Hughes says the care she has received from staff at Ysbyty Gwynedd has been "phenomenal".

The member of Parliament was given the news earlier this month

Patients with an aggressive form of breast cancer who are not candidates for immune checkpoint inhibitor therapy showed significantly improved progression-free survival when treated with the antibody drug conjugate sacituzumab govitecan…

An executive at AstraZeneca says breast-cancer drugs that the company highlighted at an industry conference over the weekend could represent $10 billion worth of company sales in five years’ time.

"And then the reality hit me that I have cancer — this is my story."

A year ago, Kim Kaufman was sitting at home, trying to piece together how her life would unfold. Her reports had come – she had breast cancer. After that, life went for a swirl. But Kaufman anchored through. Today, she’s preparing herself…

(MedPage Today) -- BERLIN -- The antibody-drug conjugate (ADC) trastuzumab deruxtecan (T-DXd, Enhertu) delivered impressive results in different HER2-positive early-stage breast cancer settings in back-to-back randomized clinical trials.

News Ghana, Latest Updates and Breaking News of Ghana, Isaac Kofi Dzokpo, https://www.newsghana.com.gh/mtn-yello-ladies-network-embarks-on-breast-cancer-awareness-walk-in-accra/As part of efforts to promote early detection and healthy…